Saturday 17 October 2026 Export MRVI’s income statement to Excel — free account

Maravai LifeSciences Holdings, Inc.

Maravai LifeSciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $185.7 million, down 28.3% from fiscal 2024. In the quarter to June 2026, revenue grew 8.53%, EPS grew 70.4%, free cash flow grew 127.6% and total debt fell 45.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

6.79 0.28 −3.96%

Follow MRVI

Alert me

Market cap: $1.8B
P/E: 0.0×
Fwd P/E: −16.2×
Dividend yield: —
F-score: 2/9
Altman Z: 0.44
Beneish M: −3.30
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	4	2	3	5
ROE Full definition →		(23.16%)	(27.53%)	(23.25%)	(18.79%)
ROA Full definition →		(11.38%)	(14.70%)	(12.50%)	(10.31%)
ROIC Full definition →		(23.73%)	(28.16%)	(22.18%)	(15.83%)
Return on Tangible Assets Full definition →		(28.61%)	(32.46%)	(29.37%)	(29.80%)
Average Days of Receivables Full definition →		42.75	50.11	59.57	54.44
Free Cash Flow per Share Full definition →		(0.46)	(0.49)	(0.36)	(0.24)
Free Cash Flow Full definition →		(66.33)	(70.72)	(52.60)	(35.84)
Capital Expenditures Full definition →		(16.88)	(13.15)	(13.08)	(10.58)
Other line items
Cash ROIC Full definition →		(6.64%)	(7.76%)	(6.53%)	(5.95%)
Accounts Receivable Turnover Full definition →		7.49	5.80	6.61	7.07
Accounts Payable Turnover Full definition →		17.37	20.41	16.03	14.58
Inventory Turnover Full definition →		3.17	3.35	3.21	3.09
Average Days of Payables Full definition →		19.22	7.00	21.52	19.13
Days of Inventory on Hand Full definition →		108.92	97.40	102.02	110.71
Tax Rate Full definition →		(0.02)	(0.02)	(0.02)	0.00
Research and Development Expense of Revenue Full definition →		9.44%	9.37%	8.01%	7.29%
Selling, General and Administrative Expense of Revenue Full definition →		80.50%	78.13%	65.77%	61.31%
Share Based Compensation of Revenue Full definition →		19.12%	16.25%	12.95%	14.34%
Interest Coverage Full definition →		(6.13)	(7.98)	(6.48)	(4.89)
Operating CF/Net income Full definition →		0.41	0.44	0.38	0.33
Depreciation/Fixed assets Full definition →		(0.31)	0.41	0.41	0.41
Capex/Depreciation Full definition →		0.34	(0.21)	(0.22)	(0.18)
Revenue per Share Full definition →		1.33	1.29	1.40	1.41
Operating CF per Share Full definition →		(0.34)	(0.40)	(0.27)	(0.17)
Capex per Share Full definition →		(0.12)	(0.09)	(0.09)	(0.07)
Capex to Sales Full definition →		0.09	0.07	0.06	0.05

Fold the line items

Columns are period end dates

Stockrow Weekly